19. A customized targeted next-generation sequencing (NGS) panel for solid tumours: Analysis of the first 100 specimens

      The aim of this study is to assess outcomes obtained on the first 105 samples using a customized solid tumour panel, covering hotspot regions in 31 genes. This 'Q31 assay' was recently implemented following a validation comprising of an amplicon-based QIAseq Targeted Panel, MiSeq, CLC Genomic Workbench for bioinformatics analysis and QCI-Interpret for variant interpretation and reporting.
      To read this article in full you will need to make a payment


      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect